4.6 Article

Design and Synthesis of Thiazolo[5,4-f]quinazolines as DYRK1A Inhibitors, Part II

Journal

MOLECULES
Volume 19, Issue 10, Pages 15411-15439

Publisher

MDPI
DOI: 10.3390/molecules191015411

Keywords

thiazolo[5,4-f]quinazolines; kinase inhibitors; DYRK1A; DYRK1B; microwave-assisted chemistry; Dimroth rearrangement; EHT 5372; EHT 6840; EHT 1610; EHT 9851; EHT 3356

Funding

  1. MESR (Ministere de l'Enseignement Superieur et de la Recherche)
  2. LABEX SynOrg [ANR-11-LABX-0029]
  3. AI-Chem Channel program
  4. European Union

Ask authors/readers for more resources

The convenient synthesis of a focused library (forty molecules) of novel 6,6,5-tricyclic thiazolo[5,4-f]quinazolines was realized mainly under microwave irradiation. A novel 6-aminobenzo[d]thiazole-2,7-dicarbonitrile (1) was used as a versatile molecular platform for the synthesis of various derivatives. Kinase inhibition, of the obtained final compounds, was evaluated on a panel of two kinases (DYRK1A/1B) together with some known reference DYRK1A and DYRK1B inhibitors (harmine, TG003, NCGC-00189310 and leucettine L41). Compound IC50 values were obtained and compared. Five of the novel thiazolo[5,4-f] quinazoline derivatives prepared, EHT 5372 (8c), EHT 6840 (8h), EHT 1610 (8i), EHT 9851 (8k) and EHT 3356 (9b) displayed single-digit nanomolar or subnanomolar IC50 values and are among the most potent DYRK1A/1B inhibitors disclosed to date. DYRK1A/ 1B kinases are known to be involved in the regulation of various molecular pathways associated with oncology, neurodegenerative diseases (such as Alzheimer disease, AD, or other tauopathies), genetic diseases (such as Down Syndrome, DS), as well as diseases involved in abnormal pre-mRNA splicing. The compounds described in this communication constitute a highly potent set of novel molecular probes to evaluate the biology/pharmacology of DYR1A/1B in such diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Medicine, Research & Experimental

DYRK1A regulates B cell acute lymphoblastic leukemia through phosphorylation of FOXO1 and STAT3

Rahul S. Bhansali, Malini Rammohan, Paul Lee, Anouchka P. Laurent, Qiang Wen, Praveen Suraneni, Bon Ham Yip, Yi-Chien Tsai, Silvia Jenni, Beat Bornhauser, Aurelie Siret, Corinne Fruit, Alexandra Pacheco-Benichou, Ethan Harris, Thierry Besson, Benjamin J. Thompson, Young Ah Goo, Nobuko Hijiya, Maria Vilenchik, Shai Izraeli, Jean-Pierre Bourquin, Sebastien Malinge, John D. Crispino

Summary: The study reveals that DYRK1A is overexpressed in and essential for B-ALL, with FOXO1 and STAT3 being critical substrates. Loss of DYRK1A-mediated FOXO1 and STAT3 signaling disrupts DNA damage and ROS regulation, leading to preferential cell death in leukemic B cells.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Article Chemistry, Physical

Copper-Catalyzed C-H Arylation of Fused-Pyrimidinone Derivatives Using Diaryliodonium Salts

Alexandra Pacheco-Benichou, Eugenie Ivendengani, Ioannis K. Kostakis, Thierry Besson, Corinne Fruit

Summary: The copper-catalyzed Csp2-Csp2 bond forming reactions through C-H activation offer a useful strategy for the diversification of heterocyclic moieties. Specific phenylation of fused-pyrimidinones, including quinazolinone, has been achieved using this method, leading to the rapid access of various arylated N-containing polyheteroaromatics as potential bioactive compounds.

CATALYSTS (2021)

Article Biochemistry & Molecular Biology

Demonstration of Green Solvent Performance on O,S,N-Heterocycles Synthesis: Metal-Free Click Chemistry and Buchwald-Hartwig Coupling

Joana F. Campos, Manon Cailler, Remi Claudel, Benjamin Prot, Thierry Besson, Sabine Berteina-Raboin

Summary: This study demonstrates the efficiency of three solvents, eucalyptol, cyclopentyl methyl ether, and 2-methyltetrahydrofuran, for the synthesis of O, S, N-heterocyclic compounds.

MOLECULES (2021)

Article Biochemistry & Molecular Biology

Microwave-Assisted Sequential One-Pot Synthesis of 8-Substituted Pyrazolo[1,5-a][1,3,5]triazines

Jonathan Elie, Corinne Fruit, Thierry Besson

Summary: This paper describes a convenient sequential one-pot approach for the synthesis of a series of 14 pyrazolo[1,5-a][1,3,5]triazines, with advantages in terms of yields, reaction times, and convenient gram scale synthesis compared to traditional methods. The combination of efficient heating using dielectric microwave heating and sequential one-pot reactions eliminates the need for laborious work-up and purification of intermediate compounds, allowing for sustainable synthesis processes.

MOLECULES (2021)

Review Chemistry, Medicinal

Recent Advances in Transition-Metal-Free Late-Stage C-H and N-H Arylation of Heteroarenes Using Diaryliodonium Salts

Thierry Besson, Corinne Fruit

Summary: This review highlights recent synthetic advances in the late-stage C(sp2)-N and C(sp2)-C(sp2) bond-forming reactions under metal-free conditions using diaryliodonium salts as arylating reagents, and discusses their applications in the synthesis of new arylated bioactive heterocyclic compounds.

PHARMACEUTICALS (2021)

Article Pharmacology & Pharmacy

A skills framework integrating professionally relevant medicinal chemistry proficiencies to strengthen the contemporary practice of pharmacy

C. Decombat, O. Duval, T. Besson, L. Bourel, M. Pudlo

Summary: The study aimed to define a competency repository in Medicinal Chemistry and provide teaching resources for pharmacy teachers. A comprehensive framework was developed based on a competency-based approach and expert reviews, highlighting the importance of Medicinal Chemistry in pharmacy studies and professional practices.

ANNALES PHARMACEUTIQUES FRANCAISES (2022)

Article Chemistry, Medicinal

Review on the Synthesis and Therapeutic Potential of Pyrido[2,3-d], [3,2-d], [3,4-d] and [4,3-d]pyrimidine Derivatives

Joana F. Campos, Thierry Besson, Sabine Berteina-Raboin

Summary: This review lists the structures composed of a pyridopyrimidine moiety that have shown therapeutic interest or have been approved for use as therapeutics. Synthetic protocols for preparing these pyridopyrimidine derivatives are considered. The review is organized into four sections, categorized by the type of pyridopyrimidine. For each compound, the biological activity and synthetic route are presented. The bibliographic research for each type of pyridopyrimidine was conducted using Reaxys and Scifinder.

PHARMACEUTICALS (2022)

Article Chemistry, Organic

Monitoring of Catalyst-Free Microwave-Assisted MCR-Type Synthesis of 2-Amino-3-cyano-4 H -chromene Derivatives Using Raman Spectrometry

Olivier Hebert, Carole Dubouilh-Benard, Joana F. Campos, Sabine Berteina-Raboin, Corinne Fruit, Thierry Besson

Summary: A series of polyfunctionalized 4H-chromenes were synthesized via a microwave-assisted and catalyst-free three-component reaction for the potential precursors of heterocyclic systems with pharmaceutical interest. Raman spectroscopy was used to monitor the microwave-heated reactions, allowing for fast and efficient optimization of process parameters. The study revealed some limitations of this monitoring tool in terms of reaction medium homogeneity. Additionally, the use of bio-sourced and sustainable solvents was investigated, with ethanol found to be the most suitable for this synthesis.

SYNTHESIS-STUTTGART (2022)

Meeting Abstract Hematology

Pharmacologic Inhibition of DYRK1A Results in Hyperactivation and Hyperphosphorylation of MYC and ERK Rendering KMT2A-R ALL Cells Sensitive to BCL2 Inhibition

V. S. S. Abhinav Ayyadevara, Gerald Wertheim, John Chukinas, Joseph Patrick Loftus, Sung June Lee, Anil Kumar, Rahul S. Bhansali, Srividya Swaminathan, Thierry Besson, Junwei Shi, John D. Crispino, Sarah K. Tasian, Martin P. Carroll, Christian Hurtz

BLOOD (2022)

Article Biochemistry & Molecular Biology

Synthesis of 2-Cyanobenzothiazoles via Pd-Catalyzed/Cu-Assisted C-H Functionalization/Intramolecular C-S Bond Formation from N-Arylcyanothioformamides

Nathan Broudic, Alexandra Pacheco-Benichou, Corinne Fruit, Thierry Besson

Summary: In this study, a catalytic system involving palladium and copper is reported for the cyclization of N-arylcyanothioformamides and the synthesis of 2-cyanobenzothiazoles. The C-H functionalization/intramolecular C-S bond formation reaction was achieved in the presence of air using 2.0 equiv of an inorganic additive (KI). The reaction led to sole product formation in good yields, allowing the synthesis of various substituted 2-cyanobenzothiazole derivatives that can be used as building blocks for the design of more complex heterocyclic or molecular labeling systems.

MOLECULES (2022)

Article Biochemistry & Molecular Biology

Straightforward Access to a New Class of Dual DYRK1A/CLK1 Inhibitors Possessing a Simple Dihydroquinoline Core

Mihaela-Liliana Tintas, Ludovic Peauger, Florent Alix, Cyril Papamicael, Thierry Besson, Jana Sopkova-de Oliveira Santos, Vincent Gembus, Vincent Levacher

Summary: The DYRK family of protein kinases, including DYRK1A and CLK1, are potential therapeutic targets for neurodegenerative diseases such as Alzheimer's disease. In this study, a new class of dihydroquinolines that inhibit hDYRK1A and hCLK1 in the nanomolar range are reported. The most potent inhibitor also exhibits antioxidant and radical scavenging properties, which are relevant in the context of Alzheimer's disease. Drug-likeness and molecular docking studies of these inhibitors are discussed.

MOLECULES (2023)

Article Chemistry, Organic

Photocatalyst-Free, Visible-Light-Mediated C-H Perfluoroalkylation of Quinazolin-4(3 H )-ones with perfluoroalkyl Iodides

Thomas Delouche, Abdoul Gadiry-Diallo, Thierry Besson, Sensuke Ogoshi, Corinne Fruit

Summary: A practical and sustainable protocol for the synthesis of perfluoroalkylated quinazolin-4(3H)-ones from quinazolin-4(3H)-ones is described. Various substituted or fused-quinazolinones are compatible, yielding mono- and bis-perfluoroalkylated compounds in moderate yields. This photocatalyst-free and visible-light-mediated C-H perfluoroalkylation offers an environmentally friendly approach to novel functionalized quinazolinone scaffolds with potential for drug discovery. Control experiments confirm the involvement of a radical mechanism.

SYNTHESIS-STUTTGART (2023)

Article Chemistry, Organic

Synthesis of Trifunctional Thiazole-Fused Anthranilonitrile and Anthranilic Acid Derivatives

Nathan Broudic, Alexandra Pacheco-Benichou, Corinne Fruit, Thierry Besson

Summary: The synthesis of trifunctional isomeric benzothiazoles derived from nitroanthranilic acids and their corresponding anthranilonitrile analogues is studied, providing a convenient access to previously unreported 2-cyanobenzothiazoles. A hydrolysis-decarboxylation sequence is then performed in an acidic medium to expand the range of relevant building blocks for further synthetic applications of these poly-functional compounds.

SYNTHESIS-STUTTGART (2023)

Article Medicine, Research & Experimental

Relieving DYRK1A repression of MKL1 confers an adult- like phenotype to human infantile megakaryocytes

Kamaleldin E. Elagib, Ashton Brock, Cara M. Clementelli, Goar Mosoyan, Lorrie L. Delehanty, Ranjit K. Sahu, Alexandra Pacheco-Benichou, Corinne Fruit, Thierry Besson, Stephan W. Morris, Koji Eto, Chintan Jobaliya, Deborah L. French, Paul Gadue, Sandeep Singh, Xinrui Shi, Fujun Qin, Robert Cornelison, Hui Li, Camelia lancu-Rubin, Camelia Iancu-Rubin, Adam N. Goldfarb

Summary: Infantile megakaryocytes have limited morphogenesis and low platelet production capacity. Deficiency of MKL1 contributes to this phenotype. Inhibitors of DYRK1A enhance morphogenesis of megakaryocytes and may alleviate clinical problems associated with their limited thrombopoietic capacity.

JOURNAL OF CLINICAL INVESTIGATION (2022)

Meeting Abstract Radiology, Nuclear Medicine & Medical Imaging

Radiosynthesis of [11C]EHT1610, a potential radioligand for quantification of cerebral DYRK1A by PET imaging

Pauline Poutrel, Fabien Fillesoye, Meziane Ibazizene, Corinne Fruit, Thierry Besson, Cecile Perrio, Fabienne Gourand

NUCLEAR MEDICINE AND BIOLOGY (2022)

No Data Available